Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Generalised quantum computational spectroscopy on a quantum chip.

Nature communications·2026
Same author

Alterations in Metabolites Associated With Umbilical Cord Blood in Monozygotic Twins Discordant for Congenital Heart Disease.

Pediatric discovery·2026
Same author

What are the primary roles of peroxidases in enzymatic browning of fresh-cut fruits and vegetables, browning promoters or ROS scavengers?

Frontiers in nutrition·2026
Same author

No cloning of quantum ensembles.

Nature communications·2026
Same author

Atrophy of specific amygdala subregion precedes the conversion from mild cognitive impairment with neuropsychiatric symptoms to dementia.

International psychogeriatrics·2026
Same author

Finite element analysis of impacted canine disimpaction: effects of anchorage systems and T-loop gable bend angles.

Frontiers in bioengineering and biotechnology·2026

Related Experiment Video

Updated: Jun 4, 2025

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
08:12

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

5.4K

HM13 is a predictive biomarker of metastasis and neutrophil infiltration in colorectal cancer.

Yanbing Ren1,2, Ying Mao2,3, Xiao Yuan2,4

  • 1Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, PR China. renyanbing2008@163.com.

Histology and Histopathology
|December 20, 2024
PubMed
Summary

High histocompatibility minor 13 (HM13) promotes colorectal cancer (CRC) growth and metastasis by reducing neutrophil infiltration. HM13 may be a therapeutic target for metastatic CRC.

More Related Videos

Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts
10:33

Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts

Published on: April 29, 2014

11.0K
Advanced Animal Model of Colorectal Metastasis in Liver: Imaging Techniques and Properties of Metastatic Clones
11:43

Advanced Animal Model of Colorectal Metastasis in Liver: Imaging Techniques and Properties of Metastatic Clones

Published on: November 30, 2016

12.6K

Related Experiment Videos

Last Updated: Jun 4, 2025

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
08:12

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

5.4K
Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts
10:33

Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts

Published on: April 29, 2014

11.0K
Advanced Animal Model of Colorectal Metastasis in Liver: Imaging Techniques and Properties of Metastatic Clones
11:43

Advanced Animal Model of Colorectal Metastasis in Liver: Imaging Techniques and Properties of Metastatic Clones

Published on: November 30, 2016

12.6K

Area of Science:

  • Oncology
  • Cancer Biology
  • Immunology

Background:

  • Histocompatibility minor 13 (HM13) is implicated in various cancer progressions.
  • The specific role of HM13 in colorectal cancer (CRC) requires further investigation.

Purpose of the Study:

  • To elucidate the functional role of HM13 in colorectal cancer (CRC).
  • To determine the relationship between HM13 expression and CRC progression, survival, and immune cell infiltration.

Main Methods:

  • Analysis of HM13 expression, clinicopathology, and survival in public databases (TCGA, TIMER2.0, GEPIA).
  • Assessment of CRC cell proliferation, migration, invasion, and adhesion following HM13 manipulation (overexpression/silencing).
  • Investigation of HM13's correlation with neutrophil infiltration and in vivo validation using CRC xenograft models.

Main Results:

  • Elevated HM13 levels in CRC correlate with malignant progression and poorer survival outcomes.
  • HM13 manipulation significantly impacts CRC cell proliferation, migration, invasion, and adhesion.
  • HM13 expression is positively associated with neutrophil infiltration and myeloperoxidase (MPO) levels in CRC.

Conclusions:

  • High HM13 expression promotes CRC tumor growth and metastasis.
  • HM13 may exert its pro-tumorigenic effects by modulating neutrophil infiltration.
  • HM13 represents a potential therapeutic target for metastatic colorectal cancer.